Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study

Melanoma survival increased with targeted- and immunotherapy agents, yet most patients ultimately progress and require salvage therapy. In our experience, some progressive disease patients on immune-checkpoint inhibitors (ICIs) demonstrate deep and sustained responses to chemotherapy. We hypothesize...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Hadash-Bengad, Reut, Hajaj, Emma, Klein, Shiri, Merims, Sharon, Frank, Stephen, Eisenberg, Galit, Yakobson, Alexander, Orevi, Marina, Caplan, Nadia, Peretz, Tamar, Lotem, Michal, Cohen, Jonatan E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7033746/
https://ncbi.nlm.nih.gov/pubmed/32117727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00070
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia